Samorita Hospital Limited (DSE:SAMORITA)
Bangladesh
· Delayed Price · Currency is BDT 55.90
+1.80 (3.33%)
At close: May 8, 2025
Samorita Hospital Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 390.83 | 378.39 | 334.27 | 338.09 | 393.62 | 321.23 | Upgrade
|
| Revenue Growth (YoY) | 3.50% | 13.20% | -1.13% | -14.11% | 22.53% | -14.20% | Upgrade
|
| Cost of Revenue | 175.35 | 162.67 | 145.76 | 148.05 | 172.75 | 142.32 | Upgrade
|
| Gross Profit | 215.48 | 215.72 | 188.5 | 190.04 | 220.87 | 178.92 | Upgrade
|
| Selling, General & Admin | 177.24 | 170.38 | 157.9 | 141.97 | 147.25 | 171.04 | Upgrade
|
| Other Operating Expenses | 0.82 | 0.82 | 1.87 | 0.64 | 0.12 | 0.16 | Upgrade
|
| Operating Expenses | 203.41 | 198.15 | 184.72 | 165.63 | 171.7 | 174.55 | Upgrade
|
| Operating Income | 12.08 | 17.57 | 3.78 | 24.41 | 49.17 | 4.37 | Upgrade
|
| Interest Expense | -4.25 | -5.44 | -6.05 | -6.93 | - | - | Upgrade
|
| Interest & Investment Income | 1.19 | 2.08 | 2.44 | 3.67 | 4.04 | 6.37 | Upgrade
|
| Earnings From Equity Investments | 0.05 | 0.04 | 0.04 | 0.04 | -0.07 | -0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.74 | 2.48 | 2.86 | 2.84 | 1.46 | 2.26 | Upgrade
|
| EBT Excluding Unusual Items | 11.81 | 16.73 | 3.07 | 24.03 | 54.61 | 12.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.18 | 0.18 | 0.03 | 0.31 | -0.07 | -2.23 | Upgrade
|
| Pretax Income | 11.99 | 16.92 | 3.1 | 24.34 | 54.53 | 10.28 | Upgrade
|
| Income Tax Expense | 0.35 | 4.72 | 2.38 | 8.04 | 12.44 | 7.03 | Upgrade
|
| Net Income | 11.64 | 12.2 | 0.72 | 16.29 | 42.09 | 3.25 | Upgrade
|
| Net Income to Common | 11.64 | 12.2 | 0.72 | 16.29 | 42.09 | 3.25 | Upgrade
|
| Net Income Growth | -4.23% | 1593.40% | -95.58% | -61.29% | 1193.89% | -89.91% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade
|
| EPS (Basic) | 0.53 | 0.56 | 0.03 | 0.75 | 1.93 | 0.15 | Upgrade
|
| EPS (Diluted) | 0.53 | 0.56 | 0.03 | 0.75 | 1.93 | 0.15 | Upgrade
|
| EPS Growth | -4.23% | 1593.42% | -95.58% | -61.29% | 1193.89% | -89.91% | Upgrade
|
| Free Cash Flow | 5.37 | 26.65 | -0.04 | -11.26 | -21.62 | -48.32 | Upgrade
|
| Free Cash Flow Per Share | 0.25 | 1.22 | -0.00 | -0.52 | -0.99 | -2.22 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | - | 0.433 | 0.866 | - | Upgrade
|
| Dividend Growth | - | - | - | -50.00% | - | - | Upgrade
|
| Gross Margin | 55.13% | 57.01% | 56.39% | 56.21% | 56.11% | 55.70% | Upgrade
|
| Operating Margin | 3.09% | 4.64% | 1.13% | 7.22% | 12.49% | 1.36% | Upgrade
|
| Profit Margin | 2.98% | 3.22% | 0.22% | 4.82% | 10.69% | 1.01% | Upgrade
|
| Free Cash Flow Margin | 1.38% | 7.04% | -0.01% | -3.33% | -5.49% | -15.04% | Upgrade
|
| EBITDA | 36 | 41.22 | 26.82 | 44.27 | 69.81 | 24.34 | Upgrade
|
| EBITDA Margin | 9.21% | 10.89% | 8.02% | 13.09% | 17.74% | 7.58% | Upgrade
|
| D&A For EBITDA | 23.93 | 23.65 | 23.04 | 19.86 | 20.64 | 19.97 | Upgrade
|
| EBIT | 12.08 | 17.57 | 3.78 | 24.41 | 49.17 | 4.37 | Upgrade
|
| EBIT Margin | 3.09% | 4.64% | 1.13% | 7.22% | 12.49% | 1.36% | Upgrade
|
| Effective Tax Rate | 2.95% | 27.88% | 76.76% | 33.06% | 22.82% | 68.36% | Upgrade
|
| Advertising Expenses | - | 1.03 | 1.02 | 0.93 | 1.01 | 2.36 | Upgrade
|
Updated Jan 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.